Epidemica is a newly established specialist evidence synthesis agency focussed on helping to bring better oncology agents successfully through clinical development and health technology appraisals.
By providing high quality systematic review, comparator mapping, model input identification, meta-analysis and network meta-analysis manuscript services to pharma, clinical researchers, key opinion leaders and ethics committee members, Epidemica aims to contribute to expediting market access of innovative oncology agents.
Epidemica is also developing decision-making support information services for patients, carers, individuals at high risk and their clinicians.